Comparison of Global versus Epidermal Growth Factor Receptor Pathway Profiling for Prediction of Lapatinib Sensitivity in Bladder Cancer

Chemotherapy for metastatic bladder cancer is rarely curative. The recently developed small molecule, lapatinib, a dual epidermal growth factor receptor (EGFR)/human epidermal growth factor receptor-2 receptor tyrosine kinase inhibitor, might improve this situation. Recent findings suggest that iden...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Havaleshko, Dmytro M, Smith, Steven Christopher, Cho, HyungJun, Cheon, Sooyoung, Owens, Charles R, Lee, Jae K, Liotta, Lance A, Espina, Virginia, Wulfkuhle, Julia D, Petricoin, Emanuel F, Theodorescu, Dan
Formato: Artigo
Lenguaje:Inglês
Publicado: Neoplasia Press Inc. 2009
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2767220/
https://ncbi.nlm.nih.gov/pubmed/19881954
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares